Overview of the Efficacy of Cetuximab in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck in Patients Who Previously Failed Platinum-based TherapiesVERMORKEN, Jan. B; HERBST, Roy S; LEON, Xavier et al.Cancer. 2008, Vol 112, Num 12, pp 2710-2719, issn 0008-543X, 10 p.Article

Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinomaCHAN, Anthony T. C; HSU, Mow-Ming; MUESER, Matthias et al.Journal of clinical oncology. 2005, Vol 23, Num 15, pp 3568-3576, issn 0732-183X, 9 p.Article

Phase I study of PM00104 (Zalypsis®) administered as a 1-hour weekly infusion resting every fourth week in patients with advanced solid tumorsMASSARD, Christophe; MARGETTS, Jane; KAHATT, Carmen et al.Investigational new drugs. 2013, Vol 31, Num 3, pp 623-630, issn 0167-6997, 8 p.Article

Phase II Trial of Weekly Alternating Sequential BIBF 1120 and Afatinib for Advanced Colorectal CancerBOUCHE, Olivier; MAINDRAULT-GOEBEL, Frederique; DUCREUX, Michel et al.Anticancer research. 2011, Vol 31, Num 6, pp 2271-2281, issn 0250-7005, 11 p.Article

Platinum-Based Chemotherapy plus Cetuximab in Head and Neck CancerVERMORKEN, Jan B; MESIA, Ricard; PEYRADE, Frederic et al.The New England journal of medicine. 2008, Vol 359, Num 11, pp 1116-1127, issn 0028-4793, 12 p.Article

Quality of Life in Head and Neck Cancer patients after Treatment with high-dose radiotherapy alone or in combination with cetuximabCURRAN, Desmond; GIRALT, Jordi; COMTE, Sylvie et al.Journal of clinical oncology. 2007, Vol 25, Num 16, pp 2191-2197, issn 0732-183X, 7 p.Article

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neckBONNER, James A; HARARI, Paul M; OVE, Roger et al.The New England journal of medicine. 2006, Vol 354, Num 6, pp 567-578, issn 0028-4793, 12 p.Article

Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapyVERMORKEN, Jan B; TRIGO, José; HITT, Ricardo et al.Journal of clinical oncology. 2007, Vol 25, Num 16, pp 2171-2177, issn 0732-183X, 7 p.Article

Phase I/II study of cetuximab in combination with cisplatin or carboplatin and fluorouracil in patients with recurrent or metastatic squamous cell carcinoma of the head and neckBOURHIS, Jean; RIVERA, Fernando; DUCK, Lionel et al.Journal of clinical oncology. 2006, Vol 24, Num 18, pp 2866-2872, issn 0732-183X, 7 p.Article

Phase II multicenter study of the antiepidermal growth factor receptor monoclonal antibody cetuximab in combination with platinum-based chemotherapy in patients with platinum-refractory metastatic and/or recurrent squamous cell carcinoma of the head and neckBASELGA, José; TRIGO, José M; BOURHIS, Jean et al.Journal of clinical oncology. 2005, Vol 23, Num 24, pp 5568-5577, issn 0732-183X, 10 p.Article